# Bryostatin 1 in Treating Patients With Stage IV Breast Cancer

> **NCT00003205** · PHASE2 · COMPLETED · sponsor: **University of Colorado, Denver**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** bryostatin 1

## Key facts

- **NCT ID:** NCT00003205
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-04
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003205, "Bryostatin 1 in Treating Patients With Stage IV Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*